Portuguese Registry on Interventional Cardiology

NCT ID: NCT01867801

Last Updated: 2017-06-09

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

50000 participants

Study Classification

OBSERVATIONAL

Study Start Date

2002-01-31

Study Completion Date

2018-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this Registry is creating a database management that allows continuous monitoring characteristics, evolution, prognostic indicators and management of patients undergoing coronary angioplasty in Portuguese Hospitals, and identify the appropriateness of clinical and interventional practice recommendations for diagnosis and treatment of coronary disease and monitoring its evolution.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Cardiovascular disease remains the main cause of death in Portugal and approximately one quarter of these are directly to ischemic heart disease. In order to better characterize percutaneous coronary intervention in Portugal, the Portuguese Society of Cardiology has promoted the Portuguese registry on percutaneous coronary intervention.

This will include all adult patients (≥ 18 years), eligible for percutaneous coronary intervention (PCI) in accordance with PCI state-of-art recommendations (including unstable and stable coronary disease). The Cardiology department where the patient has been hospitalized is responsible for the patient inclusion in the study.

Excluded patients are those in whom the preferred treatment is Coronary Artery Bypass Graft (CABG), age under 18 years or life expectancy of less than 12 months.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Coronary Artery Disease

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Patients with:

* stable angina or,
* stabilized angina pectoris or,
* atypical chest pain or,
* no chest pain but with documented silent ischemia
2. At least one stenosis is present of at least 50% in one major native epicardial coronary artery and supplying viable myocardium
3. Eligible for PCI
4. Informed consent

Exclusion Criteria

1. Patients in whom the preferred treatment is CABG;
2. Contra-indication to dual antiplatelet therapy
3. Coronary artery disease precluding PCI
4. A life expectancy of less than 1 year
5. Age under 21
Minimum Eligible Age

18 Years

Maximum Eligible Age

99 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Portuguese Association of Interventional Cardiology

OTHER

Sponsor Role collaborator

Portuguese Society of Cardiology

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Marco Costa, MD

Role: PRINCIPAL_INVESTIGATOR

Portuguese Society of Cardiology

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

CNCDC

Coimbra, , Portugal

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Portugal

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Sandra M Corker

Role: CONTACT

00351 239 838 101

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Sandra M Corker

Role: primary

00351 239 838 101

Related Links

Access external resources that provide additional context or updates about the study.

http://www.spc.pt/spc

Portuguese Society of Cardiology

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

RNCI

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Barts Revascularisation Registry
NCT05255705 RECRUITING
Registry of Secondary Revascularization
NCT03349385 ACTIVE_NOT_RECRUITING
Kitasato PCI Registry
NCT05308329 UNKNOWN
Prospective Registry on Intravascular Lithotripsy
NCT06577038 ENROLLING_BY_INVITATION
Chronic Total Occlusion Registry
NCT02352818 RECRUITING